Rational and practical considerations to guide a target product profile for patient-centric drug product development with measurable patient outcomes – A proposed roadmap-Reference-Cited by-同舟云学术

Rational and practical considerations to guide a target product profile for patient-centric drug product development with measurable patient outcomes – A proposed roadmap

Published:2022-08 Issue: Volume:177 Page:81-88
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Stegemann Sven,Sheehan Liz,Rossi Alessandra,Barrett Andrew,Paudel Amrit,Crean Abina,Ruiz Fabrice,Bresciani Massimo,Liu Fang,Shariff Zakia,Shine Margarete,Schmelzer Christel,Pense-Lheritier Anne-Marie

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference38 articles.

1. Realizing shared decision making in practice;Beach;JAMA,2019

2. Practical problems with medication use that older people experience: a qualitative study;Notenboom;J. Am. Geriat. Soc.,2014

3. A. Schenk, R. Eckardt-Felmberg, E. Steinhagen-Thiessen, S. Stegemann, Patient behavior in medication management – Findings from a patient usability study that may impact clinical outcome. Br. J. Clin. Pharmacol. (2020) 86, 1958–1968 (10.1111/bcp.13946).

4. Acceptability in the older population: the importance of an appropriate tablet size;Vallet;Pharmaceutics.,2020

5. Defining patient centric pharmaceutical drug product design;Stegemann;AAPS J.,2016

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient Acceptability and Preferences for Solid Oral Dosage Form Drug Product Attributes: A Scoping Review;Patient Preference and Adherence;2024-06

2. Involving patients in drug development for Neglected Tropical Diseases (NTDs): A qualitative study exploring and incorporating preferences of patients with cutaneous leishmaniasis into Target Product Profile development;PLOS Neglected Tropical Diseases;2024-02-21

3. Preface;Essentials of Translational Pediatric Drug Development;2024

4. Digitalizing the TIM-1 Model using Computational Approaches–Part One: TIM-1 Data Explorer;Molecular Pharmaceutics;2023-10-25

5. Drug repurposing of rimantadine for treatment of cancer;Pharmaceutical Patent Analyst;2023-09